Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

11126	Companies
245054	Keywords
173176	Articles
132194	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 04/11/2025 at 00:00, 1 year 5 months ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Onco-Innovations Limited announces groundbreaking study on adjusting bias in real-world oncology research, published in JAMA Network Open, offering a method to enhance clinical comparisons

Bias Analysis Onco-Innovations Limited Real-world Oncology Research JAMA Network Open Clinical Comparisons
BRIEF

published on 04/04/2025 at 00:05, 1 year 6 months ago

Inka Health's Analytical Achievements for AstraZeneca Canada Highlighted at ISPOR 2025

Real-world Evidence Pharmaceutical Analytics ISPOR 2025 Healthcare Decision-Making AstraZeneca Collaboration
BRIEF

published on 04/04/2025 at 00:05, 1 year 6 months ago

Les réalisations analytiques d'Inka Health pour AstraZeneca Canada mises en lumière à l'ISPOR 2025

Preuves Du Monde Réel ISPOR 2025 Analyse Pharmaceutique Prise De Décision En Matière De Soins De Santé Collaboration Avec AstraZeneca
PRESS RELEASE

published on 04/04/2025 at 00:00, 1 year 6 months ago

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Onco-Innovations Limited's subsidiary, Inka Health Corp., completes analytical work for AstraZeneca Canada, showcasing advancements in pharmaceutical evidence generation and real-world data use

Real-world Data Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Pharmaceutical Evidence Generation
BRIEF

published on 03/26/2025 at 23:05, 1 year 6 months ago

Study Explores Low Toxicity of Onco-Innovations' PNKP Technology

Cancer Treatment Radiation Therapy Onco-Innovations PNKP Technology Low Toxicity
BRIEF

published on 03/26/2025 at 23:05, 1 year 6 months ago

Une étude explore la faible toxicité de la technologie PNKP d'Onco-Innovations

Traitement Du Cancer Radiothérapie Onco-Innovations Technologie PNKP Faible Toxicité
PRESS RELEASE

published on 03/26/2025 at 23:00, 1 year 6 months ago

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Onco-Innovations Limited announces successful nanoparticle formulation of PNKP Compound with low toxicity and effective cancer cell targeting in mice, promising safer treatment options

Cancer Treatment Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Low Toxicity
BRIEF

published on 03/25/2025 at 22:05, 1 year 6 months ago

Onco-Innovations Extends Marketing Partnership with MCS

Digital Advertising Onco-Innovations Marketing Extension MCS Partnership CAD 600,000 Budget
BRIEF

published on 03/25/2025 at 22:05, 1 year 6 months ago

Onco-Innovations étend son partenariat marketing avec MCS

Publicité Numérique Onco-Innovations Extension Marketing Partenariat MCS Budget De 600 000 $ CA
PRESS RELEASE

published on 03/25/2025 at 22:00, 1 year 6 months ago

Onco-Innovations Extends Marketing Program
Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until May 31, 2025. Company aims to revolutionize cancer treatment with patented technology

Patented Technology Cancer Treatment Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services

Accesswire

Published on 10/05/2026 at 14:45, 6 hours 48 minutes ago

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 7 hours 3 minutes ago

Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 7 hours 3 minutes ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 7 hours 33 minutes ago

Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 7 hours 33 minutes ago

GameSquare to Present at Upcoming Investor Conferences

View all ACCESSWIRE

EQS Group

Published on 10/05/2026 at 21:10, 23 minutes ago

Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Published on 10/05/2026 at 21:05, 27 minutes ago

EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE
Published on 10/05/2026 at 20:15, 1 hour 17 minutes ago

EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Published on 10/05/2026 at 20:09, 1 hour 23 minutes ago

EQS-Adhoc: 1&1 AG resolves capital increase from authorized capital in exchange for a contribution in kind by United Internet AG
Published on 10/05/2026 at 19:30, 2 hours 3 minutes ago

EEII AG: Suspension of the Jubin Frères SA Reverse Takeover

Les Echos

Published on 10/05/2026 at 18:13, 3 hours 20 minutes ago

Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 3 hours 20 minutes ago

Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 3 hours 33 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
Published on 10/05/2026 at 17:45, 3 hours 48 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 10/05/2026 at 17:45, 3 hours 48 minutes ago

Declaration of voting rights at the end of September 2026

View all LES ECHOS COMFI WIRE